Loading…
Notify Americans Before Outsourcing Personal Information Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 6,490 other HR bills in the 111th — cohort avg 44d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2010 · fourth_quarter · Homeland Security
HR122/S141 Protecting the Privacy of Social Security Numbers Act of 2009; HR220 Identity Theft Prevention Act; HR427 Notify Americans Before Outsourcing Personal Information Act; HR1467 Safe and Secure American Act of 2009; HR1617 Department of Homeland Security Component Privacy Officer Act of 2009; HR 1800 National Security Letters Reform Act of 2009; S773 Cybersecurity Act of 2009
Client expense: $59,465 · Firm income: Not reported
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Homeland Security
HR122/S141 Protecting the Privacy of Social Security Numbers Act of 2009; HR220 Identity Theft Prevention Act; HR427 Notify Americans Before Outsourcing Personal Information Act; HR1467 Safe and Secure American Act of 2009; HR1617 Department of Homeland Security Component Privacy Officer Act of 2009; HR 1800 National Security Letters Reform Act of 2009; S773 Cybersecurity Act of 2009
Client expense: $63,452 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Homeland Security
HR122/S141 Protecting the Privacy of Social Security Numbers Act of 2009; HR220 Identity Theft Prevention Act; HR427 Notify Americans Before Outsourcing Personal Information Act; HR1467 Safe and Secure American Act of 2009; HR1617 Department of Homeland Security Component Privacy Officer Act of 2009; HR 1800 National Security Letters Reform Act of 2009; S773 Cybersecurity Act of 2009
Client expense: $71,573 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Homeland Security
HR122/S141 Protecting the Privacy of Social Security Numbers Act of 2009; HR220 Identity Theft Prevention Act; HR427 Notify Americans Before Outsourcing Personal Information Act; HR1467 Safe and Secure American Act of 2009; HR1617 Department of Homeland Security Component Privacy Officer Act of 2009; HR 1800 National Security Letters Reform Act of 2009; S773 Cybersecurity Act of 2009
Client expense: $163,360 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Health Issues
S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, H.R. 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation, HR 4872 Health Care Reconcilation Act of 2010, HR 3590 Patient Protection and Affordable Care Act S 1679 Affordable Health Choices Act; HR 3961Medicare Physician Payment Reform Act of 2009; S 1796 America's Healthy Future Act of 2009; HR 3962 Affordable Health Care for America Act; HR 3590 Senate Leadership's Health Care Overhaul; H.R. 1995 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2009, FTC Report "Emerging Health Care Issues: Follow-on Bilogic Drug Competition," mental health parity, value based insurance design, quality of care, adhereance.
Client expense: $421,094 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE
2010 · first_quarter · Copyright/Patent/Trademark
S. 515, S. 610 and HR 1260 Patent Reform Acts; H.R. 427 Promoting Innovation and Access to Live-saving Medicine Act, HR 1548 Pathway for Biosimilars Act, S. 726 Licensing of biosimilar/biogeneric products, H.R. 1706 Protecting Consumer Access to Generic Drugs, general patent reform and settlement issues, general follow-on-biologic issues, S 1679 Affordable Health Choices Act, HR 3961Medicare Physician Payment Reform Act of 2009; S 1796 America's Healthy Future Act of 2009; HR 3962 Affordable Health Care for America Act; HR 3590 Senate Leadership's Health Care Overhaul; S 1504 Notice of Pleading Restoration Act of 2009
Client expense: $421,094 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE
2009 · third_quarter · Homeland Security
HR122/S141 Protecting the Privacy of Social Security Numbers Act of 2009; HR220 Identity Theft Prevention Act; HR427 Notify Americans Before Outsourcing Personal Information Act; HR1467 Safe and Secure American Act of 2009; HR1617 Department of Homeland Security Component Privacy Officer Act of 2009; HR 1800 National Security Letters Reform Act of 2009; S773 Cybersecurity Act of 2009
Client expense: $149,324 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Copyright/Patent/Trademark
S. 515, S. 610 and HR 1260 Patent Reform Acts; H.R. 427 Promoting Innovation and Access to Live-saving Medicine Act, HR 1548 Pathway for Biosimilars Act, S. 726 Licensing of biosimilar/biogeneric products, H.R. 1706 Protecting Consumer Access to Generic Drugs, general patent reform and settlement issues, general follow-biologic issues
Client expense: $525,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2009 · second_quarter · Health Issues
S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, H.R. 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance health reformoptions H.R. 1995 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2009, FTC Report "Emerging Health Care Issues: Follow-on Bilogic Drug Competition," mental health parity, value based insurance design
Client expense: $525,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2009 · second_quarter · Copyright/Patent/Trademark
S. 515, S. 610 and HR 1260 Patent Reform Acts; H.R. 427 Promoting Innovation and Access to Live-saving Medicine Act, HR 1548 Pathway for Biosimilars Act, S. 726 Licensing of biosimilar/biogeneric products, H.R. 1706 Protecting Consumer Access to Generic Drugs, general patent reform and settlement issues, general follow-biologic issues
Client expense: $525,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2009 · second_quarter · Health Issues
S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, H.R. 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance health reformoptions H.R. 1995 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2009, FTC Report "Emerging Health Care Issues: Follow-on Bilogic Drug Competition," mental health parity, value based insurance design
Client expense: $525,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2009 · first_quarter · Health Issues
H.R. 1 The American Recovery and Reinvestment Act, S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, HR 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation
Client expense: $450,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Copyright/Patent/Trademark
S. 515, S. 610 and HR 1260 Patent Reform Acts; H.R. 427 Promoting Innovation and Access to Live-saving Medicine Act, HR 1548 Pathway for Biosimilars Act, S. 726 Licensing of biosimilar/biogeneric products
Client expense: $450,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · fourth_quarter · Health Issues
S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, H.R. 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation, S 1679 Affordable Health Choices Act; HR 3961Medicare Physician Payment Reform Act of 2009; S 1796 America's Healthy Future Act of 2009; HR 3962 Affordable Health Care for America Act; HR 3590 Senate Leadership's Health Care Overhaul; H.R. 1995 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2009, FTC Report "Emerging Health Care Issues: Follow-on Bilogic Drug Competition," mental health parity, value based insurance design, quality of care, adhereance.
Client expense: $465,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE
2009 · fourth_quarter · Copyright/Patent/Trademark
S. 515, S. 610 and HR 1260 Patent Reform Acts; H.R. 427 Promoting Innovation and Access to Live-saving Medicine Act, HR 1548 Pathway for Biosimilars Act, S. 726 Licensing of biosimilar/biogeneric products, H.R. 1706 Protecting Consumer Access to Generic Drugs, general patent reform and settlement issues, general follow-on-biologic issues, S 1679 Affordable Health Choices Act, HR 3961Medicare Physician Payment Reform Act of 2009; S 1796 America's Healthy Future Act of 2009; HR 3962 Affordable Health Care for America Act; HR 3590 Senate Leadership's Health Care Overhaul; S 1504 Notice of Pleading Restoration Act of 2009
Client expense: $465,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), SENATE
2009 · fourth_quarter · Homeland Security
HR122/S141 Protecting the Privacy of Social Security Numbers Act of 2009; HR220 Identity Theft Prevention Act; HR427 Notify Americans Before Outsourcing Personal Information Act; HR1467 Safe and Secure American Act of 2009; HR1617 Department of Homeland Security Component Privacy Officer Act of 2009; HR 1800 National Security Letters Reform Act of 2009; S773 Cybersecurity Act of 2009
Client expense: $72,957 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE
2009 · third_quarter · Health Issues
S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, H.R. 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance health reformoptions H.R. 1995 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2009, FTC Report "Emerging Health Care Issues: Follow-on Bilogic Drug Competition," mental health parity, value based insurance design, quality of care, adhereance.
Client expense: $254,295 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2009 · third_quarter · Copyright/Patent/Trademark
S. 515, S. 610 and HR 1260 Patent Reform Acts; H.R. 427 Promoting Innovation and Access to Live-saving Medicine Act, HR 1548 Pathway for Biosimilars Act, S. 726 Licensing of biosimilar/biogeneric products, H.R. 1706 Protecting Consumer Access to Generic Drugs, general patent reform and settlement issues, general follow-on-biologic issues
Client expense: $254,295 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2009 · third_quarter · Homeland Security
HR122/S141 Protecting the Privacy of Social Security Numbers Act of 2009; HR220 Identity Theft Prevention Act; HR427 Notify Americans Before Outsourcing Personal Information Act; HR1467 Safe and Secure American Act of 2009; HR1617 Department of Homeland Security Component Privacy Officer Act of 2009; HR 1800 National Security Letters Reform Act of 2009; S773 Cybersecurity Act of 2009
Client expense: $161,191 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE
2009 · second_quarter · Health Issues
S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, H.R. 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation, H.R. 3200/S. _____ America's Affordable Health Choices Act of 2009 and Senate Finance health reformoptions H.R. 1995 Eliminating Disparities in Diabetes Prevention Access and Care Act of 2009, FTC Report "Emerging Health Care Issues: Follow-on Bilogic Drug Competition," mental health parity, value based insurance design
Client expense: $450,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2009 · second_quarter · Copyright/Patent/Trademark
S. 515, S. 610 and HR 1260 Patent Reform Acts; H.R. 427 Promoting Innovation and Access to Live-saving Medicine Act, HR 1548 Pathway for Biosimilars Act, S. 726 Licensing of biosimilar/biogeneric products, H.R. 1706 Protecting Consumer Access to Generic Drugs, general patent reform and settlement issues, general follow-biologic issues
Client expense: $450,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2009 · second_quarter · Homeland Security
HR122/S141 Protecting the Privacy of Social Security Numbers Act of 2009; HR220 Identity Theft Prevention Act; HR427 Notify Americans Before Outsourcing Personal Information Act; HR1467 Safe and Secure American Act of 2009; HR1617 Department of Homeland Security Component Privacy Officer Act of 2009; HR 1800 National Security Letters Reform Act of 2009; S773 Cybersecurity Act of 2009
Client expense: $149,324 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Homeland Security
HR122/S141 Protecting the Privacy of Social Security Numbers Act of 2009; HR220 Identity Theft Prevention Act; HR427 Notify Americans Before Outsourcing Personal Information Act; HR1467 Safe and Secure American Act of 2009; HR1617 Department of Homeland Security Component Privacy Officer Act of 2009; HR 1800 National Security Letters Reform Act of 2009; S773 Cybersecurity Act of 2009.
Client expense: $163,360 · Firm income: Not reported
Government targets: Consumer Product Safety Commission (CPSC), HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Health Issues
H.R. 1 The American Recovery and Reinvestment Act, S. 301 Physician Payment Sunshine Act, S. 537 Sunshine in Litigation Act, S. 623 The Pre-existing Condition Patient Protection Act, H.R. 427 Promoting Innovation and Access to Life-Saving Medicine Act, HR 1548 Pathway for Biosimilars Act, S. 726 Licensing of Biosimilar/Biogeneric Products, general comparative effectiveness issues, general health reform and the un/underinsured, general diabetes legislation
Client expense: $375,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2009 · first_quarter · Copyright/Patent/Trademark
S. 515, S. 610 and HR 1260 Patent Reform Acts; H.R. 427 Promoting Innovation and Access to Live-saving Medicine Act, HR 1548 Pathway for Biosimilars Act, S. 726 Licensing of biosimilar/biogeneric products
Client expense: $375,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE